RNU6-703P

Across TCGA pan-cancer cohorts, RNU6-703P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNU6-703P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RNU6-703P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-703P is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

LIHC, THCA, and KICH are the cancer types where RNU6-703P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-703P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.402	<.001	5	view →
THCA	Female	All	−0.802	<.001	4	view →
KICH	All	All	−0.584	.003	3	view →
STAD	All	II,III,IV	+0.488	.017	3	view →
LUSC	Female	III,IV	+0.960	.037	1	view →
CHOL	All	All	+0.921	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RNU6-703P–LIHC

Open the LIHC breakdown →